Details
Stereochemistry | ACHIRAL |
Molecular Formula | 2C9H6NO7S2.4C4H11N.Cu |
Molecular Weight | 964.646 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Cu++].CCNCC.CCNCC.CCNCC.CCNCC.OS(=O)(=O)C1=CC(=C2C=CC=NC2=C1[O-])S(O)(=O)=O.OS(=O)(=O)C3=CC(=C4C=CC=NC4=C3[O-])S(O)(=O)=O
InChI
InChIKey=NHRTVBMNRNCBLQ-UHFFFAOYSA-L
InChI=1S/2C9H7NO7S2.4C4H11N.Cu/c2*11-9-7(19(15,16)17)4-6(18(12,13)14)5-2-1-3-10-8(5)9;4*1-3-5-4-2;/h2*1-4,11H,(H,12,13,14)(H,15,16,17);4*5H,3-4H2,1-2H3;/q;;;;;;+2/p-2
Cuproxoline is a copper complex used in a veterinary as a copper supplement. Cuproxoline was also used for the treatment of rheumatoid arthritis, where it was administered by intravenous or intramuscular injections. Clinical studies has shown that cuproxoline therapy gave good results for the treatment of rheumatoid arthritis which had been active for less than a year, even if the patient had become resistant to gold therapy.
Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
5029
Created by
admin on Fri Dec 15 16:16:20 GMT 2023 , Edited by admin on Fri Dec 15 16:16:20 GMT 2023
|
PRIMARY | |||
|
SUB06834MIG
Created by
admin on Fri Dec 15 16:16:20 GMT 2023 , Edited by admin on Fri Dec 15 16:16:20 GMT 2023
|
PRIMARY | |||
|
13007-93-7
Created by
admin on Fri Dec 15 16:16:20 GMT 2023 , Edited by admin on Fri Dec 15 16:16:20 GMT 2023
|
PRIMARY | |||
|
71855
Created by
admin on Fri Dec 15 16:16:20 GMT 2023 , Edited by admin on Fri Dec 15 16:16:20 GMT 2023
|
PRIMARY | |||
|
C83641
Created by
admin on Fri Dec 15 16:16:20 GMT 2023 , Edited by admin on Fri Dec 15 16:16:20 GMT 2023
|
PRIMARY | |||
|
m3930
Created by
admin on Fri Dec 15 16:16:20 GMT 2023 , Edited by admin on Fri Dec 15 16:16:20 GMT 2023
|
PRIMARY | Merck Index | ||
|
100000083725
Created by
admin on Fri Dec 15 16:16:20 GMT 2023 , Edited by admin on Fri Dec 15 16:16:20 GMT 2023
|
PRIMARY | |||
|
C1505
Created by
admin on Fri Dec 15 16:16:20 GMT 2023 , Edited by admin on Fri Dec 15 16:16:20 GMT 2023
|
CONCEPT | Dietary Supplement | ||
|
X36RBY88G2
Created by
admin on Fri Dec 15 16:16:20 GMT 2023 , Edited by admin on Fri Dec 15 16:16:20 GMT 2023
|
PRIMARY |
PARENT (SALT/SOLVATE)
PARENT (SALT/SOLVATE)
SUBSTANCE RECORD